Science & Technology

UC Davis Launches Neuroscience Consortium

September 29, 2021

(DAVIS) Today the University of California, Davis, officially launched a consortium called the UC Davis Neuroscience Consortium (UCDNC) to leverage the strength, breadth, and depth of one of the largest neuroscience communities in the world. The consortium brings together nearly 300 researchers from 12 centers and 41 departments — integrating biologists, chemists, social scientists, engineers, computer scientists, and clinicians.

Researchers Identify a Potentially Safer Approach to Opioid Drug Development

(SACRAMENTO) — Opioids are powerful painkillers but their use is hindered because patients become tolerant to them, requiring higher and higher doses, and overdoses can cause respiratory depression and death.

A recent study from researchers at the UC Davis Center for Neuroscience contradicts existing thinking about how opioid drugs cause tolerance and respiratory depression, and suggests a new, balanced approach to developing safer analgesics.

Faculty Spotlight: Professor Carolynn Patten, Ph.D., P.T., F.A.P.T.A.

Dr. Carolynn Patten’s translational neuroscience and neurorehabilitation research combines expertise in neurophysiology, neuroimaging, biomechanical, behavioral and clinical approaches to studying human performance pre- and post-injury. Her research focuses on understanding the neural basis of human movement as well as investigating human motor control and learning from a neuromechanics perspective. A neuroscientist and physical therapist, Patten specializes in the assessment and treatment of motor dysfunction associated with aging and adult neuropathologies such as stroke.